National report - Dermatologists seem to be greeting calls for a single national registry for clinical drug trials with a collective shrug of their shoulders.
Deuruxolitinib Shows Efficacy in Hair Regrowth, Patient Satisfaction, and Psychosocial Wellbeing in Severe Alopecia Areata
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Melinda Gooderham, MSc, MD, FRCPC: Insights Into Lebrikizumab’s Sustained 3-Year Efficacy
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Post Hoc Analysis of Vilobelimab in Hidradenitis Suppurativa Suggests Clinically Meaningful Benefits
Upadacitinib Demonstrates Efficacy in Patients With AD and Head and Neck Involvement